Ob.Gyn. NewsTRAIN-2: Anthracyclines added toxicity, with no increased efficacy, in HER2+ breast cancerMay 30, 2020Breast Cancer
Ob.Gyn. NewsPembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancerMay 29, 2020Breast Cancer
Ob.Gyn. NewsActive cancer increases death risk in patients with COVID-19May 28, 2020Breast CancerCOVID-19 UpdatesMixed Topics
Ob.Gyn. NewsPatient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020COVID-19 UpdatesPractice ManagementBreast CancerGynecologyMixed Topics
Ob.Gyn. NewsMammography cuts risk for fatal breast cancers: New dataMay 13, 2020Breast CancerPreventive Care
Ob.Gyn. NewsCOVID-19 death rate was twice as high in cancer patients in NYC studyMay 5, 2020COVID-19 UpdatesBreast CancerGynecologic CancerPractice Management
Ob.Gyn. NewsThree months of COVID-19 may mean 80,000 missed cancer diagnosesMay 4, 2020Practice ManagementBreast CancerGynecologic CancerPreventive CareCOVID-19 Updates
Ob.Gyn. NewsCancer screening, monitoring down during pandemicMay 4, 2020Practice ManagementCOVID-19 UpdatesBreast CancerGynecologic CancerPreventive Care
Ob.Gyn. NewsAdding a blood test to standard screening may improve early cancer detectionMay 1, 2020Breast CancerGynecologic CancerPreventive Care
Ob.Gyn. NewsExcess cancer deaths predicted as care is disrupted by COVID-19May 1, 2020Breast CancerCOVID-19 UpdatesGynecologic CancerPractice ManagementPreventive Care
Ob.Gyn. NewsAntitumor treatment may increase risk of severe events in COVID-19 patientsMay 1, 2020Breast CancerCOVID-19 UpdatesGynecologic Cancer
